ImmunityBio (IBRX) Common Equity (2014 - 2026)
ImmunityBio (IBRX) posted Common Equity of -$1.05 billion for Q2 2026, compared with -$569.82 million a year earlier.
Powered by 
Analysis
ImmunityBio (IBRX) Common Equity (2014 - 2026) Analysis & Trends
At the end of FY2025, ImmunityBio's Common Equity came in at -$500.47 million.
- In prior years, ImmunityBio's Common Equity was -$488.13 million in FY2024, -$585.94 million in FY2023, -$449.82 million in FY2022 and -$243.91 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Common Equity in data going back to Q4 2014.
- According to Business Quant data, Common Equity for the three prior quarters was -$869.13 million (Q1 2026), -$500.47 million (Q4 2025) and -$524.32 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 89.30 Bn |
| 10 | ImmunityBio | 7.48 Bn | 6.24 Bn | 50.94 Mn | -1.05 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.05 Bn |
| Mar 31, 2026 | -869.13 Mn |
| Dec 31, 2025 | -500.47 Mn |
| Sep 30, 2025 | -524.32 Mn |
| Jun 30, 2025 | -569.82 Mn |
| Mar 31, 2025 | -590.48 Mn |
| Dec 31, 2024 | -488.13 Mn |
| Sep 30, 2024 | -744.16 Mn |
| Jun 30, 2024 | -697.38 Mn |
| Mar 31, 2024 | -690.98 Mn |
| Dec 31, 2023 | -585.94 Mn |
| Sep 30, 2023 | -410.65 Mn |
| Jun 30, 2023 | -645.18 Mn |
| Mar 31, 2023 | -531.72 Mn |
| Dec 31, 2022 | -449.82 Mn |
| Sep 30, 2022 | -429.08 Mn |
| Jun 30, 2022 | -421.97 Mn |
| Mar 31, 2022 | -337.56 Mn |
| Dec 31, 2021 | -243.91 Mn |
| Sep 30, 2021 | -189.94 Mn |
API Access
ImmunityBio Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();